Avantor, Inc.

NYSE:AVTR 주식 리포트

시가총액: US$5.4b

Avantor 과거 순이익 실적

과거 기준 점검 0/6

Avantor 의 수입은 연평균 -20.9%의 비율로 감소해 온 반면, Life Sciences 산업은 연평균 4.6%의 비율로 감소했습니다. 매출은 연평균 2.4%의 비율로 감소해 왔습니다.

핵심 정보

-20.89%

순이익 성장률

-23.06%

주당순이익(EPS) 성장률

Life Sciences 산업 성장률21.51%
매출 성장률-2.35%
자기자본이익률-9.87%
순이익률-8.42%
최근 순이익 업데이트31 Mar 2026

최근 과거 실적 업데이트

Recent updates

Avantor Q1 2026 Earnings Review: Stabilization Emerging, But Recovery Not Yet Visible

Apr 30

AVTR: Expanded Quality Control Capabilities Will Support Execution Turnaround And Future Share Repricing

Analysts have trimmed their average price targets on Avantor, and the updated fair value estimate now stands at about $16.47. This reflects a softer sentiment around the stock as research notes point to share losses, reduced investment, and questions about management's ability to stabilize the business.

AVTR: Reset Expectations And Share Repurchases May Support Future Upside

The analyst price target for Avantor has shifted lower to reflect a series of Street target cuts, including a move to $8.50. This change stems from concerns about share losses, constrained investment, and uncertainty over whether management can stabilize the business.

AVTR: Execution Turnaround In Core Franchise Will Drive Future Share Repricing

Analysts have lowered their price targets on Avantor, with the updated fair value estimate moving from about $17.68 to $16.13 as they factor in concerns about share losses, underinvestment, and uncertainty around management's ability to stabilize the business, along with a higher assumed discount rate and P/E multiple. Analyst Commentary Recent Street research has tilted cautious on Avantor, highlighted by a downgrade to Underweight with a US$8.50 price target and several cuts to prior price targets.

AVTR: Reset Expectations And Buybacks Will Support Future Upside Potential

Analysts have cut their average price target on Avantor by a few dollars to reflect lower fair value estimates, softer assumed revenue growth and profit margins, and a higher future P/E multiple in light of recent broad target reductions from firms across the Street. Several have moved targets in a $2 to $4 range, and one reset its view from $14 to $12.

The Market Doesn't Like What It Sees From Avantor, Inc.'s (NYSE:AVTR) Revenues Yet As Shares Tumble 27%

Feb 13
The Market Doesn't Like What It Sees From Avantor, Inc.'s (NYSE:AVTR) Revenues Yet As Shares Tumble 27%

AVTR: Service Expansion And Execution Will Drive Upside From Reset Expectations

Narrative Update: Avantor Analyst Price Target Shift Analysts recently trimmed their price target on Avantor to $12 from $14. This reflects updated views on the life science tools sector and a Q4 outlook where many companies have already set softer expectations for 2026.

AVTR: Share Repurchases And Execution Risks Will Shape Turnaround Visibility

Analysts have trimmed their price target on Avantor by about $0.60, reflecting more cautious assumptions on revenue growth and future P/E. This is partly offset by slightly higher profit margin expectations and a marginally lower discount rate.

AVTR: Execution Turnaround And Review Process Will Unlock Share Repricing Potential

Avantor's analyst price targets and fair value estimates have inched higher to around $17.68 per share. At the same time, lower assumed revenue growth, a higher discount rate, a reduced future P/E, and sharply higher profit margin expectations reflect analysts' mixed views following recent downgrades and concerns about execution and visibility.

AVTR: Share Repurchases Will Drive Upside As Turnaround Visibility Improves

Analysts have modestly lowered their price targets on Avantor by a few dollars per share, generally to the low to mid teens in dollar terms. They cite reduced guidance, weaker quarters and limited visibility around the company’s turnaround and strategic review.

AVTR: Share Repurchase Initiative And Execution Will Shape Recovery Prospects Ahead

Analysts have lowered their price target for Avantor from $14 to $12 per share, citing a weak quarter, reduced guidance, and ongoing execution risks as primary concerns behind the updated outlook. Analyst Commentary Bullish Takeaways Bullish analysts have raised price targets ahead of quarterly results, reflecting improved confidence in Avantor’s long-term positioning despite current volatility.

AVTR: Share Repurchase And Execution Will Define Turnaround Prospects In 2025

Avantor’s analyst price target has decreased from $13.80 to $13.64. Analysts cite reduced company guidance, execution risks, and ongoing uncertainty surrounding its earnings outlook as key factors driving the revision.

Avantor, Inc. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts

Nov 01
Avantor, Inc. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts

AVTR: Activist Pressure And Business Overhaul Will Drive Share Recovery

Avantor’s analyst price target has been reduced from $14.40 to $13.80 per share, as analysts cite ongoing operational headwinds and limited near-term earnings visibility following recent downgrades and mixed guidance. Analyst Commentary Recent analyst notes on Avantor capture a divided outlook, reflecting both positive updates from some firms and notable caution from others as the company contends with ongoing operational challenges.

There's No Escaping Avantor, Inc.'s (NYSE:AVTR) Muted Earnings Despite A 28% Share Price Rise

Oct 28
There's No Escaping Avantor, Inc.'s (NYSE:AVTR) Muted Earnings Despite A 28% Share Price Rise

Pharma Contracts And R&D Will Drive Growth Amid Price Pressures

Analysts have modestly increased their price target for Avantor, raising it by $0.28 to $14.40. They cite revised expectations for end market recovery and alignment with company outlooks.

We Think Avantor (NYSE:AVTR) Is Taking Some Risk With Its Debt

Sep 12
We Think Avantor (NYSE:AVTR) Is Taking Some Risk With Its Debt

Concerns Surrounding Avantor's (NYSE:AVTR) Performance

Aug 12
Concerns Surrounding Avantor's (NYSE:AVTR) Performance

What Is Avantor, Inc.'s (NYSE:AVTR) Share Price Doing?

Jun 26
What Is Avantor, Inc.'s (NYSE:AVTR) Share Price Doing?

Earnings Working Against Avantor, Inc.'s (NYSE:AVTR) Share Price

May 14
Earnings Working Against Avantor, Inc.'s (NYSE:AVTR) Share Price

Avantor: A Healthier Diagnosis As Expectations Cool

Apr 26

Avantor: Mundane Business, Solid Cash Flow, Potential New Risks

Mar 07

Avantor: Durable FCF Generator Trading For Cheap

Dec 18

Avantor: Uninspiring, Even Amidst Some Green Shoots

Oct 24
User avatar

New Operating Model And Bioprocessing Innovations Promise Robust Growth And Market Leadership

Implementation of a new operating model and ongoing cost transformation initiatives are streamlining execution and improving net margins through cost savings.

Avantor: Yet To Evidence Economic Value For Valuation Repricing, Reiterate Hold

Aug 13

매출 및 비용 세부 내역

Avantor가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.

순이익 및 매출 추이

NYSE:AVTR 매출, 비용 및 순이익 (USD Millions)
날짜매출순이익일반관리비연구개발비
31 Mar 266,552-5511,5880
31 Dec 256,552-5301,5740
30 Sep 256,575-821,5060
30 Jun 256,6666871,5560
31 Mar 256,6857161,5350
31 Dec 246,7847121,5540
30 Sep 246,8203101,6160
30 Jun 246,8263601,5450
31 Mar 246,8672601,4970
31 Dec 236,9673211,4660
30 Sep 237,0393641,4700
30 Jun 237,1764231,4750
31 Mar 237,3426101,4690
31 Dec 227,5126621,4520
30 Sep 227,6255981,4420
30 Jun 227,6035721,4450
31 Mar 227,5515341,4630
31 Dec 217,3865081,4260
30 Sep 217,2694661,4420
30 Jun 217,0402671,3880
31 Mar 216,6601691,3450
31 Dec 206,394521,3420
30 Sep 206,127711,3360
30 Jun 206,0261351,3320
31 Mar 206,079-2261,3340
31 Dec 196,040-3351,3290
30 Sep 195,990-5141,2940
30 Jun 195,981-5541,3030
31 Mar 195,926-3301,3050
31 Dec 185,864-3561,3210
30 Sep 185,120-6391,2150
31 Dec 171,247-4153760
31 Dec 16691-422570
31 Dec 15637221850

양질의 수익: AVTR 은(는) 현재 수익성이 없습니다.

이익 마진 증가: AVTR는 현재 수익성이 없습니다.

잉여현금흐름 대비 순이익 분석

과거 순이익 성장 분석

수익추이: AVTR은 수익성이 없으며 지난 5년 동안 손실이 연평균 20.9% 증가했습니다.

성장 가속화: 현재 수익성이 없어 지난 1년간 AVTR의 수익 성장률을 5년 평균과 비교할 수 없습니다.

수익 대 산업: AVTR은 수익성이 없어 지난 해 수익 성장률을 Life Sciences 업계(2.5%)와 비교하기 어렵습니다.

자기자본이익률

높은 ROE: AVTR는 현재 수익성이 없으므로 자본 수익률이 음수(-9.87%)입니다.

총자산이익률

투하자본수익률

우수한 과거 실적 기업을 찾아보세요

7D

1Y

7D

1Y

7D

1Y

기업 분석 및 재무 데이터 상태

데이터최종 업데이트 (UTC 시간)
기업 분석2026/04/30 02:44
종가2026/04/30 00:00
수익2026/03/31
연간 수익2025/12/31

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지데이터기간미국 소스 예시 *
기업 재무제표10년
  • 손익계산서
  • 현금흐름표
  • 대차대조표
분석가 컨센서스 추정치+3년
  • 재무 예측
  • 분석가 목표주가
시장 가격30년
  • 주가
  • 배당, 분할 및 기타 조치
지분 구조10년
  • 주요 주주
  • 내부자 거래
경영진10년
  • 리더십 팀
  • 이사회
주요 개발10년
  • 회사 공시

* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.

Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

Avantor, Inc.는 29명의 분석가가 다루고 있습니다. 이 중 14명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가기관
Catherine Ramsey SchulteBaird
Luke SergottBarclays
Michael RyskinBofA Global Research